These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2319610)

  • 1. Improved therapeutic index of cisplatin by procaine hydrochloride.
    Esposito M; Fulco RA; Collecchi P; Zicca A; Cadoni A; Merlo F; Rosso R; Sobrero A
    J Natl Cancer Inst; 1990 Apr; 82(8):677-84. PubMed ID: 2319610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
    Esposito M; Viale M; Vannozzi MO; Zicca A; Cadoni A; Merlo F; Gogioso L
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):370-7. PubMed ID: 8887454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent influence of procaine hydrochloride on cisplatin antitumor activity in P388 tumor bearing mice.
    Viale M; Vánnozzi MO; Mandys V; Esposito M
    Anticancer Res; 2001; 21(1A):485-7. PubMed ID: 11299784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cis-diamminedichloroplatinum (II)-procaine pharmacokinetic interaction in mice bearing P388 leukemia.
    Esposito M; Vannozzi MO; Viale M; Pellecchia C; Merlo F; Cadoni A; Cafaggi S; Parodi B; Lerza R; Poirier MC
    Anticancer Res; 1993; 13(5A):1511-6. PubMed ID: 8239529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
    Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
    Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride.
    Cafaggi S; Esposito M; Parodi B; Vannozzi MO; Viale M; Pellecchia C; Fulco RA; Merlo F; Zicca A; Cadoni A
    Anticancer Res; 1992; 12(6B):2285-92. PubMed ID: 1295476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin combined with the new cisplatin-procaine complex DPR: in vitro and in vivo studies.
    Viale M; Vannozzi MO; Merlo F; Cafaggi S; Parodi B; Esposito M
    Eur J Cancer; 1996 Dec; 32A(13):2327-33. PubMed ID: 9038617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thymidine on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II).
    Grossie VB; Valdivieso M; Drewinko B; Loo TL
    Cancer Chemother Pharmacol; 1984; 13(1):27-30. PubMed ID: 6539657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of coadministration of selenite on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II) given repeatedly to mice.
    Satoh M; Naganuma A; Imura N
    Cancer Chemother Pharmacol; 1992; 30(6):439-43. PubMed ID: 1394800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of normal saline on cisplatin pharmacokinetics and antitumor activity in mice bearing P388 leukemia.
    Fulco RA; Vannozzi M; Collecchi P; Merlo F; Parodi B; Civalleri D; Esposito M
    Anticancer Res; 1990; 10(6):1603-10. PubMed ID: 2285232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimum schedule of selenium administration to reduce lethal and renal toxicities of cis-diamminedichloroplatinum in mice.
    Satoh M; Naganuma A; Imura N
    J Pharmacobiodyn; 1989 Apr; 12(4):246-53. PubMed ID: 2795434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect on cisplatin hematotoxicity by procaine hydrochloride.
    Esposito M; Lerza R; Mencoboni M; Vannozzi M; Flego G; Bogliolo G; Merlo F; Pannacciulli I
    Cancer Lett; 1992 May; 64(1):55-60. PubMed ID: 1596878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia.
    Vannozzi MO; Ottone M; Mariggiò MA; Cafaggi S; Parodi B; Cilli M; Lindup E; Viale M
    Anticancer Res; 2003; 23(2B):1509-16. PubMed ID: 12820417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin combined with tiopronin or sodium thiosulfate: cytotoxicity in vitro and antitumor activity in vivo.
    Viale M; Zhang JG; Pastrone I; Mariggiò MA; Esposito M; Lindup WE
    Anticancer Drugs; 1999 Apr; 10(4):419-28. PubMed ID: 10378678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
    Harrison SD; O'Dwyer PJ; Trader MW
    Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing mice.
    Keizer HJ; Pauwels R; Landuyt W; Balzarini J; van der Schueren E; De Clercq E
    Cancer Lett; 1988 Mar; 39(2):217-23. PubMed ID: 3359416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle.
    Aamdal S; Fodstad O; Kaalhus O; Pihl A
    J Natl Cancer Inst; 1984 Sep; 73(3):743-52. PubMed ID: 6590919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy of early and advanced murine P388 leukaemia with bouvardin, cis-diamminedichloroplatinum and vincristine.
    Adwankar MK; Khandalekar DD; Chitnis MP
    Oncology; 1984; 41(5):370-3. PubMed ID: 6540853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schedule-dependent variations in the response of murine P388 leukemia to cyclophosphamide in combination with interferons-alpha/beta.
    Borden EC; Sidky YA; Hatcher JF; Bryan GT
    Cancer Res; 1988 May; 48(9):2329-34. PubMed ID: 3356000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.